Modeling the evolution of SARS-CoV-2 under non-pharmaceutical interventions
View ORCID ProfileYael Gurevich, View ORCID ProfileYoav Ram, View ORCID ProfileLilach Hadany
doi: https://doi.org/10.1101/2021.02.20.21252133
Yael Gurevich
1School of Plant Sciences and Food Security, Faculty of Life Sciences, Tel-Aviv University, Tel-Aviv, 6997801, Israel
Yoav Ram
2School of Zoology, Faculty of Life Sciences, Tel-Aviv University, Tel-Aviv, 6997801, Israel
Lilach Hadany
1School of Plant Sciences and Food Security, Faculty of Life Sciences, Tel-Aviv University, Tel-Aviv, 6997801, Israel
Data Availability
The code used to produce the results is available upon request.
Posted February 23, 2021.
Modeling the evolution of SARS-CoV-2 under non-pharmaceutical interventions
Yael Gurevich, Yoav Ram, Lilach Hadany
medRxiv 2021.02.20.21252133; doi: https://doi.org/10.1101/2021.02.20.21252133
Subject Area
Subject Areas
- Addiction Medicine (401)
- Allergy and Immunology (712)
- Anesthesia (204)
- Cardiovascular Medicine (2965)
- Dermatology (250)
- Emergency Medicine (444)
- Epidemiology (12785)
- Forensic Medicine (12)
- Gastroenterology (829)
- Genetic and Genomic Medicine (4610)
- Geriatric Medicine (423)
- Health Economics (732)
- Health Informatics (2939)
- Health Policy (1070)
- Hematology (392)
- HIV/AIDS (927)
- Medical Education (429)
- Medical Ethics (116)
- Nephrology (474)
- Neurology (4392)
- Nursing (237)
- Nutrition (646)
- Oncology (2284)
- Ophthalmology (650)
- Orthopedics (259)
- Otolaryngology (327)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (502)
- Pediatrics (1199)
- Primary Care Research (501)
- Public and Global Health (6982)
- Radiology and Imaging (1539)
- Respiratory Medicine (917)
- Rheumatology (443)
- Sports Medicine (385)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (182)